Reporting adverse drug reactions for doctors and pharmacists

The reporting of suspected adverse drug reactions by healthcare professionals is one of the key pillars of drug safety. These reports play a vital role in the detection of potential drug risks at an early stage and the continuous monitoring of the benefit/risk profile of all available medicines. This particularly applies to reports of serious and/or previously unknown ADRs which, according to Art. 59 of the Therapeutic Products Act (TPA), are subject to mandatory notification.

Healthcare professionals can report directly to Swissmedic. The reports are processed and assessed in close cooperation with the regional pharmacovigilance centres in Basel, Bern, Geneva, Lausanne, Zurich and Lugano.

Two options are available for reporting to Swissmedic:

  1. Electronic reports via ElViS (Electronic Vigilance System)
  2. Report form

ElViS Hotline for technical support only

+41 58 462 06 00

Mon-Fri from 07:30 - 17:30

Last modification 05.03.2021

Top of page